Display options
Share it on

ACS Med Chem Lett. 2015 May 26;6(7):787-92. doi: 10.1021/acsmedchemlett.5b00122. eCollection 2015 Jul 09.

Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors.

ACS medicinal chemistry letters

Yonghui Wang, Wei Cai, Yaobang Cheng, Ting Yang, Qian Liu, Guifeng Zhang, Qinghua Meng, Fangbin Han, Yafei Huang, Ling Zhou, Zhijun Xiang, Yong-Gang Zhao, Yan Xu, Ziqiang Cheng, Sijie Lu, Qianqian Wu, Jia-Ning Xiang, John D Elliott, Stewart Leung, Feng Ren, Xichen Lin

Affiliations

  1. School of Pharmacy, Fudan University , 826 Zhangheng Road, Pudong, Shanghai 201203, China.
  2. Research and Development, GlaxoSmithKline , No. 3 Building, 898 Halei Road, Pudong, Shanghai 201203, China.

PMID: 26191367 PMCID: PMC4499822 DOI: 10.1021/acsmedchemlett.5b00122

Abstract

A novel series of biaryl amides was identified as RORγt inhibitors through core replacement of a starting hit 1. Structure-activity relationship exploration on the biaryl moiety led to discovery of potent RORγt inhibitors with good oral bioavailability and CNS penetration. Compounds 9a and 9g demonstrated excellent in vivo efficacy in EAE mice dose dependently with once daily oral administration.

Keywords: EAE; RORγt inhibitor; Th17 cell differentiation; biaryl amides; multiple sclerosis

References

  1. Immunity. 2012 Jan 27;36(1):23-31 - PubMed
  2. J Immunol. 2006 Jul 1;177(1):566-73 - PubMed
  3. Nature. 2011 Apr 28;472(7344):491-4 - PubMed
  4. ACS Med Chem Lett. 2013 Jan 10;4(1):79-84 - PubMed
  5. Trends Pharmacol Sci. 2014 Oct;35(10):493-500 - PubMed
  6. J Biol Chem. 2011 Jul 1;286(26):22707-10 - PubMed
  7. Bioorg Med Chem Lett. 2014 May 1;24(9):2182-7 - PubMed
  8. ACS Med Chem Lett. 2013 Nov 22;5(1):65-8 - PubMed
  9. Nat Immunol. 2008 Jun;9(6):641-9 - PubMed
  10. Cell. 2006 Sep 22;126(6):1121-33 - PubMed
  11. Drug Discov Today. 2014 Aug;19(8):1205-11 - PubMed
  12. Eur J Immunol. 2012 Sep;42(9):2232-7 - PubMed
  13. J Biol Chem. 2010 Feb 12;285(7):5013-25 - PubMed
  14. Trends Endocrinol Metab. 2012 Dec;23(12):619-27 - PubMed
  15. Mult Scler. 1999 Apr;5(2):101-4 - PubMed
  16. Immunity. 2014 Apr 17;40(4):477-89 - PubMed
  17. Bioorg Med Chem. 2014 Jan 15;22(2):692-702 - PubMed
  18. Immunity. 2014 Apr 17;40(4):451-2 - PubMed
  19. Nature. 2011 Apr 28;472(7344):486-90 - PubMed
  20. J Med Chem. 2014 Jul 24;57(14):5871-92 - PubMed
  21. J Autoimmun. 2008 Nov;31(3):252-6 - PubMed
  22. Nat Rev Drug Discov. 2014 Feb;13(2):105-21 - PubMed
  23. Mol Pharmacol. 2012 Oct;82(4):583-90 - PubMed
  24. ACS Chem Biol. 2012 Apr 20;7(4):672-7 - PubMed
  25. Cell Res. 2014 Aug;24(8):901-3 - PubMed
  26. Bioorg Med Chem. 2014 Mar 15;22(6):1948-59 - PubMed
  27. Bioorg Med Chem Lett. 2013 Dec 15;23 (24):6604-9 - PubMed
  28. Eur J Med Chem. 2014 May 6;78:431-41 - PubMed
  29. Immunity. 2008 Jan;28(1):29-39 - PubMed
  30. Bioorg Med Chem Lett. 2014 Aug 15;24(16):3891-7 - PubMed
  31. Chem Biol. 2012 Jan 27;19(1):51-9 - PubMed
  32. Am J Pathol. 2008 Jan;172(1):146-55 - PubMed
  33. Nat Med. 2002 May;8(5):500-8 - PubMed
  34. ACS Chem Biol. 2012 Sep 21;7(9):1515-9 - PubMed
  35. Bioorg Med Chem. 2014 May 1;22(9):2799-808 - PubMed

Publication Types